Deprenyl blocks the aglycemia-induced depression of the synaptic transmission but not the ischemia-induced depression in neonatal rat spinal cord in vitro

Neuroscience Research

Volumn 47, Issue 1, 2003, Pages 23-29

  Jha, Archana ^a   Das Gupta, Shyamal ^a   Deshpande, Shripad B ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Anoxia; Creatine phosphate; Ischemia; MAO B inhibitor; Monosynaptic reflex; Polysynaptic reflex

Indexed keywords

CREATINE PHOSPHATE; SELEGILINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DORSAL ROOT; ENERGY METABOLISM; FEMALE; GLUCOSE BLOOD LEVEL; HYPOXIA; ISCHEMIA; MALE; MONOSYNAPTIC REFLEX; NEUROPROTECTION; NONHUMAN; POLYSYNAPTIC REFLEX; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL REFLEX; SYNAPTIC TRANSMISSION; VENTRAL ROOT;

EID: 0043163800     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-0102(03)00159-7     Document Type: Article

References (29)

1. +-ATPase activities in adult rat whole brain. Pharmacol. Res. 46:2002;165-169.
2. Carp J.S., Ohno Y., Warnick J.E. Prevention of phencyclidine-induced depression of the segmental reflex by 1-3,4-dihydroxy-phenylalanine in the rat spinal cord in vitro. J. Pharmacol. Exp. Ther. 248:1989;1048-1053.
3. Carrillo M.C., Kitani K., Sato Y., Ivy G.O. The ability of (-) deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective. Life Sci. 50:1992;1985-1992.
4. Czeh G., Somjen G.G. Hypoxic failure of synaptic transmission in the isolated spinal cord and the effects of divalent cations. Brain Res. 527:1990;224-233.
5. Deshpande S.B. Significance of monosynaptic and polysynaptic reflexes in neonatal rat spinal cord in vitro. Indian J. Exp. Biol. 31:1993;850-854.
6. Deshpande S.B., Das Gupta S. Diisopropylphosphoro-fluoridate-induced depression of segmental monosynaptic transmission in neonatal rat spinal cord is also mediated by increased axonal activity. Toxicol. Lett. 90:1997;177-182.
7. Deshpande S.B., Warnick J.E. Receptor subtypes involved in mediating serotonin-induced depression of the spinal monosynaptic reflex in vitro. Manchanda S.K., Selvamurthy W., Mohan Kumar V. Advances in Physiological Sciences. 1992;631-635 MacMillan India Ltd, New Delhi.
8. Deshpande S.B., Warnick J.E. Thyrotropin-releasing hormone reverses the supersensitively depressed monosynaptic transmission by serotonin in 5,7 dihydroxytryptamine treated neonatal rats in vitro. Brain Res. 655:1994;263-266.
9. Deshpande S.B., Pilotte N.S., Warnick J.E. Gender specific action of thyrotropin-releasing hormone in the mammalian spinal cord. FASEB J. 1:1987;478-482.
10. 2+ exchanger. Exp. Neurol. 145:1997;38-45.
11. Ebadi M., Sharma S., Shavali S., El Refaey H. Neuroprotective actions of selegiline. J. Neurosci. Res. 67:2002;285-289.
12. Elliott P., Wallis D.I. Serotonin and L-norepinephrine as mediators of altered excitability in neonatal rat motoneurons studied in vitro. Neuroscience. 47:1992;533-544.
13. Holschneider D.P., Scremin O.U., Huynh L., Chen K., Shih J.C. Lack of protection from ischemic injury of monoamine oxidase B-deficient mice following middle cerebral artery occlusion. Neurosci. Lett. 259:1999;161-164.
14. Iadecola C. Bright and dark sides of nitric oxide in ischemic brain injury. Trends Neurosci. 20:1997;132-139.
15. Jahr C.E., Yoshioka K. Ia afferent excitation of motoneurones in the in vitro new born rat spinal cord is selectively antagonised by kynurenate. J. Physiol. 370:1986;515-530.
16. Knoll J. The pharmacology of (-) deprenyl. J. Neural. Transm. Suppl. 22:1986;75-89.
17. Knollema S., Aukema W., Hom H., Korf J. L-Deprenyl reduces brain damage in rats exposed to transient hypoxia-ischemia. Stroke. 26:1995;1883-1887.
18. Kuhmonen J., Jolkkonen J., Haapalinna A., Sivenius J. The neuroprotective effects of (-) deprenyl in the gerbil hippocampus following transient global ischemia. J. Neural. Transm. 107:2000;779-786.
19. Leret M.L., San Millan J.A., Fabre E., Gredilla R., Barja G. Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum. Toxicology. 170:2002;165-171.
20. Martin G.R., Eglen R.M. The 5-hydroxytryptamine receptor. Trends Pharmacol. Sci. 19:1998;2-4.
21. Mattson M.P., Zhang Y., Bose S. Growth factors prevent mitochondrial dysfunction, loss of calcium homeostasis and cell injury, but not ATP depletion in hippocampal neurons deprived of glucose. Exp. Neurol. 121:1993;1-13.
22. 3H] noradrenaline and glutamate in response to simulation of ischemic conditions in rat spinal cord slice preparation: effect of NMDA and AMPA receptor antagonists. Eur. J. Pharmacol. 366:1999;143-150.
23. Pringle A.K., Iannotti F., Wilde G.J.C., Chad J.E., Seeley P.J., Sundstorm L.E. Neuroprotection by both NMDA and non NMDA receptor antagonists in vitro ischemia. Brain Res. 755:1997;36-46.
24. Ravikumar R., Lakshmana B.S., Shankaranarayana Rao B.S., Meti B.L., Bindu P.N., Raju T.R. (-)-Deprenyl attenuates spinal motor neuron degeneration and associated locomotor deficits in rat subjected to spinal cord ischemia. Exp. Neurol. 149:1998;123-129.
25. Santos M.S., Moreno A.J., Carvalho A.P. Relationships between ATP depletion, membrane potential and the release of neurotransmitters in rat nerve terminals. Stroke. 27:1996;941-950.
26. Simon L., Szilagyi G., Bori Z., Orbay P., Nagy Z. (-)-D-Deprenyl attenuates apoptosis in experimental brain ischemia. Eur. J. Pharmacol. 430:2001;235-241.
27. Singh J.N., Deshpande S.B. Involvement of N-methyl-D-aspartate receptors for the Ptychodiscus brevis toxin- induced depression of monosynaptic and polysynaptic reflexes in neonatal rat spinal cord in vitro. Neuroscience. 115:2002;1189-1197.
28. Stys P.K. Anoxic and ischemic injury of myelinated axons in CNS white matter: from mechanistic concepts to therapeutics. J. Cereb. Blood Flow Metab. 18:1998;2-25.
29. Wang M.Y., Dun N.J. 5-Hydroxytryptamine responses in neonatal rat motoneurons in vitro. J. Physiol. 430:1990;87-103.